Does SECUKINUMAB Cause Therapy non-responder? 1,376 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,376 reports of Therapy non-responder have been filed in association with SECUKINUMAB (COSENTYX). This represents 0.9% of all adverse event reports for SECUKINUMAB.
1,376
Reports of Therapy non-responder with SECUKINUMAB
0.9%
of all SECUKINUMAB reports
497
Deaths
802
Hospitalizations
How Dangerous Is Therapy non-responder From SECUKINUMAB?
Of the 1,376 reports, 497 (36.1%) resulted in death, 802 (58.3%) required hospitalization, and 672 (48.8%) were considered life-threatening.
Is Therapy non-responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 1,376 reports have been filed with the FAERS database.
What Other Side Effects Does SECUKINUMAB Cause?
Drug ineffective (27,434)
Psoriasis (21,976)
Pain (15,244)
Arthralgia (13,769)
Fatigue (9,406)
Psoriatic arthropathy (8,900)
Pruritus (8,755)
Malaise (8,570)
Rash (8,023)
Condition aggravated (7,536)
What Other Drugs Cause Therapy non-responder?
ETANERCEPT (3,472)
APREMILAST (3,360)
METHOTREXATE (2,965)
RITUXIMAB (2,731)
ADALIMUMAB (2,595)
PREDNISONE (2,563)
TREPROSTINIL (2,289)
INFLIXIMAB (2,122)
TOCILIZUMAB (1,775)
HYDROXYCHLOROQUINE (1,699)
Which SECUKINUMAB Alternatives Have Lower Therapy non-responder Risk?
SECUKINUMAB vs SELADELPAR LYSINE
SECUKINUMAB vs SELEGILINE
SECUKINUMAB vs SELENIUM
SECUKINUMAB vs SELENIUM SULFIDE
SECUKINUMAB vs SELEXIPAG